口腔颌面外科杂志Issue(1)：72-76,5.DOI:10.3969/j.issn.1005-4979.2015.01.016
AMD3100促进骨组织再生的研究进展
Advances of AMD3100 in Bone Regeneration
摘要
Abstract
AMD3100, trade name Plerixafor, is one of mobilization agents used for hemopoietic stem cell transplantation. Due to its specific pharmacological effects of blocking the SDF-1/CXCR4 biological axis, AMD3100 can mobilize hematopoietic stem cells (HSC), endothelial progenitor cells (EPC), and mesenchymal stem cells (MSC) from bone marrow. More and more researches trying to use AMD3100 to accelerate bone regeneration. In this review we focus on the relevant researches that applying AMD3100 to accelerate bone regeneration.关键词
AMD3100/普乐沙福/干细胞动员/骨再生/SDF-1/CXCR4轴Key words
AMD3100/Plerixafor/stem cell mobilization/bone regeneration/SDF-1/CXCR4 axis分类
医药卫生引用本文复制引用
陈丹莹(综述),王佐林(审校)..AMD3100促进骨组织再生的研究进展[J].口腔颌面外科杂志,2015,(1):72-76,5.基金项目
国家自然科学基金(81271110) （81271110）
